RT Journal Article
SR Electronic
T1 What we could do now: molecular pathology of gynaecological cancer
JF Molecular Pathology
JO Mol Pathol
FD BMJ Publishing Group Ltd and Association of Clinical Pathologists
SP 222
OP 224
DO 10.1136/mp.54.4.222
VO 54
IS 4
A1 C S Herrington
YR 2001
UL http://mp.bmj.com/content/54/4/222.abstract
AB Gynaecological tumours exemplify many of the molecular paradigms of carcinogenesis. The clinical value of many of the molecular abnormalities present is now being tested and it is likely that the identification of at least some of these will become routine in the near future. This may help to refine diagnosis and guide treatment—for example, therapeutic vaccination for human papillomavirus related disease.